Lexaria Corp. (OTC: LXRP), an aspiring producer of medical marijuana under Canada’s MMPR program and a developer of hemp-based CBD products, recently announced that it engaged Michelle Reillo, PhD, to write a series of manuals providing guidance to both consumers of CBD and practitioners who advise patients in their use of CBD. The series will focus on how to maximize health, performance, and wellness using the compounds.

“We are very excited to have Dr. Reillo write these education manuals on Lexaria’s behalf,” said Chris Bunka, CEO of Lexaria Corp. “The CBD industry is in its infancy, and the benefits of CBD consumption are only just now being understood. We believe that as a producer of CBD products, it is our obligation to make sure that our customers understand how to use our products to achieve the maximum health and performance benefits possible.”

The series discuss how the human cannabinoid systems function and will address the specific CBD needs of athletes, the aging, alcohol and nicotine users, caregivers, those suffering from chronic illness, and others. In addition, the series will cover how CBD helps the body’s physiology, how to optimize CBD consumption, and how to use CBD to potentially achieve certain health, wellness, and performance results, among other things.

These efforts are designed to tie into the company’s ViPova brand of hemp-based CBD products, which will initially include a line of teas. Using a patent-pending process, the company infuses concentrated amounts of CBDs contained within lipids into food and beverage products. The inclusion of lipids assists with absorption and could make the products more efficacious than other CBD products on the market.

Shares of Lexaria Corp. jumped more than 3% in early trading the day after the announcement was made.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.